Oscotec Inc. (KOSDAQ:039200)

South Korea flag South Korea · Delayed Price · Currency is KRW
50,400
-1,600 (-3.08%)
Feb 13, 2026, 3:30 PM KST
Market Cap1.93T +84.4%
Revenue (ttm)23.23B -27.3%
Net Income-13.14B
EPS-343.51
Shares Out38.26M
PE Ration/a
Forward PE482.05
Dividendn/a
Ex-Dividend Daten/a
Volume283,508
Average Volume511,305
Open51,900
Previous Close52,000
Day's Range49,650 - 51,900
52-Week Range24,500 - 66,000
Beta1.48
RSI51.83
Earnings DateMar 19, 2026

About Oscotec

Oscotec Inc. operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses. It develops SKI-O-703, a SYK inhibitor that is in Phase 2 clinical trials to treat rheumatoid arthritis and idiopathic thrombocytopenic purpura; SKI-G-801, a selective FLT3/AXL inhibitor, which is in Phase I clinical trial for the treatment of acute myeloid leukemia, as well as other solid tumors; and lazertinib, a 3rd generation EGFR inhibitor that is in Phase 3 clinical trials... [Read more]

Sector Healthcare
Founded 1998
Employees 53
Stock Exchange KOSDAQ
Ticker Symbol 039200
Full Company Profile

Financial Performance

Financial Statements